Zobrazeno 1 - 10
of 146
pro vyhledávání: '"Hideo Shichinohe"'
Autor:
Soichiro Takamiya, Masahito Kawabori, Tsukasa Kitahashi, Kentaro Nakamura, Yuki Mizuno, Hironobu Yasui, Yuji Kuge, Aki Tanimori, Yasuyuki Takamatsu, Kohei Yuyama, Hideo Shichinohe, Miki Fujimura
Publikováno v:
Stem Cells International, Vol 2022 (2022)
Background. Due to the lack of effective therapies, stem cell transplantation is an anticipated treatment for chronic intracerebral hemorrhage (ICH), and higher cell survival and engraftment are considered to be the key for recovery. Mesenchymal stro
Externí odkaz:
https://doaj.org/article/5663bf5c969941958d31f88679ccb2cd
Publikováno v:
Stem Cells International, Vol 2021 (2021)
Externí odkaz:
https://doaj.org/article/2fe5f2e058014a77a5741035a9c690fc
Publikováno v:
Stem Cells International, Vol 2020 (2020)
Cell therapy for central nervous system (CNS) disorders is beginning to prove its safety and efficiency. Intraparenchymal transplantation can be an option for cell delivery; however, one concern regarding this method is that the transplantation cannu
Externí odkaz:
https://doaj.org/article/232425c575c94efb9216eee81aab95f6
Autor:
Chengbo Tan, Songji Zhao, Kei Higashikawa, Zifeng Wang, Masahito Kawabori, Takeo Abumiya, Naoki Nakayama, Ken Kazumata, Naoyuki Ukon, Hironobu Yasui, Nagara Tamaki, Yuji Kuge, Hideo Shichinohe, Kiyohiro Houkin
Publikováno v:
EJNMMI Research, Vol 8, Iss 1, Pp 1-10 (2018)
Abstract Background The potential application of bone marrow stromal cell (BMSC) therapy in stroke has been anticipated due to its immunomodulatory effects. Recently, positron emission tomography (PET) with [18F]DPA-714, a translocator protein (TSPO)
Externí odkaz:
https://doaj.org/article/7945544cd8ce48dea20a009cc287cdbd
Autor:
Hideo Shichinohe, Masahito Kawabori, Hiroaki Iijima, Tuyoshi Teramoto, Takeo Abumiya, Naoki Nakayama, Ken Kazumata, Shunsuke Terasaka, Teruyo Arato, Kiyohiro Houkin
Publikováno v:
BMC Neurology, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background Stroke is a leading cause of death and disability, and despite intensive research, few treatment options exist. However, a recent breakthrough in cell therapy is expected to reverse the neurological sequelae of stroke. Although so
Externí odkaz:
https://doaj.org/article/06757642f38e48fc8257f8f1710b35d1
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 19, p 7380 (2020)
Despite recent developments in innovative treatment strategies, stroke remains one of the leading causes of death and disability worldwide. Stem cell therapy is currently attracting much attention due to its potential for exerting significant therape
Externí odkaz:
https://doaj.org/article/e7c4c0945cc54cb59e75fd0f983ee549
Autor:
Michiyuki Miyamoto, Kentaro Nakamura, Hideo Shichinohe, Tomohiro Yamauchi, Masaki Ito, Hisayasu Saito, Masahito Kawabori, Toshiya Osanai, Tasuku Sasaki, Kiyohiro Houkin, Satoshi Kuroda
Publikováno v:
Stem Cells International, Vol 2018 (2018)
Bone marrow stromal cell (BMSC) transplantation has the therapeutic potential for ischemic stroke. However, it is unclear which delivery routes would yield both safety and maximal therapeutic benefits. We assessed whether a novel recombinant peptide
Externí odkaz:
https://doaj.org/article/0213e4a9c7e946e5a92613721d72b098
Publikováno v:
Brain Circulation, Vol 1, Iss 1, Pp 88-96 (2015)
Moyamoya disease (MMD) is characterized by a progressive steno-occlusive disease affecting the terminal portions of the cerebral internal carotid artery (ICA) and by formation of an abnormal vascular network at the base of the brain. Several pathogen
Externí odkaz:
https://doaj.org/article/59d97bc698bb495cb02ef76f6c5a450a
Autor:
Shuji Hamauchi, Hideo Shichinohe, Haruto Uchino, Shigeru Yamaguchi, Naoki Nakayama, Ken Kazumata, Toshiya Osanai, Takeo Abumiya, Kiyohiro Houkin, Takumi Era
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163561 (2016)
Moyamoya disease (MMD) is a slow, progressive steno-occlusive disease, arising in the terminal portions of the cerebral internal carotid artery. However, the functions and characteristics of the endothelial cells (ECs) in MMD are unknown. We analyzed
Externí odkaz:
https://doaj.org/article/b6395d8d767e44ec90e4a364574b7659
Autor:
Chengbo Tan, Hideo Shichinohe, Zifeng Wang, Shuji Hamauchi, Takeo Abumiya, Naoki Nakayama, Ken Kazumata, Tsuneo Ito, Kohsuke Kudo, Shigeru Takamoto, Kiyohiro Houkin
Publikováno v:
Stem Cells International, Vol 2016 (2016)
Currently, there is increasing interest in human bone marrow stromal cells (hBMSCs) as regeneration therapy against cerebral stroke. The aim of the present study was to evaluate the feasibility and validity of hBMSC cultures with allogeneic platelet
Externí odkaz:
https://doaj.org/article/6ae5e44d5f424efea9e20e3dba6694a0